Re: "Circulating levels of KL-6 in acute respiratory distress syndrome sepsis or traumatic brain injury in critically ill children" by Briassoulis et al. (Pediatr Pulmonol 2006; 41:790-795).
Eisenhut
Michael
M
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications* / Q000378:metabolism; D018118:Chloride Channels / Q000502:physiology; D002712:Chlorides / Q000378:metabolism*; D000242:Cyclic AMP / Q000502:physiology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000502:physiology; D004847:Epithelial Cells / Q000378:metabolism; D006801:Humans; D011650:Pulmonary Alveoli / Q000166:cytology / Q000378:metabolism; D011654:Pulmonary Edema / Q000188:drug therapy / Q000378:metabolism*; D012123:Pulmonary Ventilation; D020545:Respiratory Mucosa / Q000378:metabolism*; D018805:Sepsis / Q000150:complications*; D012964:Sodium / Q000378:metabolism
D000318:Adrenergic beta-Agonists; D018118:Chloride Channels; D002712:Chlorides; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D012964:Sodium; D000242:Cyclic AMP